Figure 3. Identification and verification of the target CBL of MiRNA-122-5p in human SSC line. (A–E) Real-time qPCR revealed the relative levels of ZNF668 (A), PLAG1 (B), MEF2D (C), FOXP1 (D) and CBL (E) in human SSCs of miRNA-122-5p vector and control lentivirus. * indicated statistically significant differences (p< 0.05) in human SSC line between control lentivirus and miRNA-122-5p vector. (F) Western blots depicted CBL protein in human SSC line of miRNA-122-5p vector and control lentivirus. (G) The relative expression levels of CBL protein in human SSC line of miRNA-122-5p vector and control lentivirus after normalization to the signals of their loading control ACTB. * denoted statistically significant differences (p< 0.05) in human SSC line between control lentivirus and miRNA-122-5p vector. (H, I) Validation of the targeting of miRNA-122-5p to wild type CBL and mutated CBL by dual luciferase reporter assays. (J, K) Validation of the targeting of miRNA-122-5p to wild type ZNF668 and mutated ZNF668 by dual luciferase reporter assays. * implied statistically significant differences (p< 0.05) in human SSC line between miRNA-122-5p mimics and miRNA mimics control. (L) Schematic diagram illustrated the binding site of miRNA-122-5p to CBL mRNA.